|
|
|
| Clinical Observation of Treating Elderly Hepatitis B Cirrhosis with Insomnia with WuMei Pill Decoction |
| NIU Jinhu, WANG Yizhen |
| Hanzhong Railway Central Hospital, Hanzhong Shaanxi 723000 |
|
|
|
Abstract 【Objective】To investigate the clinical efficacy of Wumei Pill decoction in treating elderly hepatitis B cirrhosis with insomnia. 【Methods】A total of 76 elderly patients with hepatitis B cirrhosis and insomnia who were admitted to Hanzhong Railway Central Hospital from February 2018 to October 2019 were selected. They were divided into observation group (n=38) and control group (n=38) according to the random number table method. The control group received conventional basic treatment, while the observation group received oral administration of Wumei Pill decoction on the basis of the treatment in the control group. Both groups were treated for 2 weeks. Sleep quality was evaluated before and after treatment in both groups. The levels of liver function indicators total bilirubin (TBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and albumin (ALB) were analyzed before and after treatment in both groups. The prothrombin time (PT) and the occurrence of adverse reactions were compared between the two groups before and after treatment.【Results】 After treatment, the PSQI index in both groups was lower than before treatment, with that in the observation group being lower than in the control group (P<0.05). After treatment, TBIL, PT, ALT, and AST in both groups were lower than before treatment (P<0.05), while ALB was higher than before treatment (P<0.05). AST, TBIL, ALT, and PT in the observation group after treatment were lower than those in the control group (P<0.05), while ALB was significantly higher than that in the control group (P<0.05). The incidence of adverse reactions in the observation group was 15.79%, and that in the control group was 21.05%, without significant difference (χ2=0.35, P>0.05). 【Conclusion】Wumei Pill can effectively improve sleep quality and liver function in elderly patients with hepatitis B cirrhosis and insomnia without significant adverse reactions, with high safety and certain clinical promotion value.
|
|
Received: 26 August 2022
|
|
|
|
|
|
[1] 陈霞, 俞莹莹, 戴再友,等. 乙型肝炎肝硬化患者医院获得性感染的危险因素分析及ImmuKnow法监测免疫细胞功能的价值[J].中华肝脏病杂志, 2017, 25(1):41-43.
[2] GUO H M, LIU M, XIANG Y T, et al. Insomnia in adults with chronic hepatitis B, liver failure, and cirrhosis:a case-control study[J].Perspect Psychiatr Care,2017, 53(1):67-72.
[3] 王忠琼,刘翼,夏国栋. 前列地尔对乙肝肝硬化患者血清炎性因子及肝功能的影响[J].医学研究生学报, 2017, 30(6):611-614.
[4] 王爱华,李国焕.乌梅丸治疗慢性乙肝患者失眠经验总结[J].中国现代药物应用,2017,11(6):178-180.
[5] 崔国宁, 刘喜平. 乌梅丸治疗溃疡性结肠炎研究进展[J].山东中医杂志, 2018,37(2):170-173.
[6] 科技部十二五重大专项联合课题组. 乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理[J].中华消化杂志, 2014, 30(2):138-148.
[7] 中华医学会神经病学分会, 中华医学会神经病学分会睡眠障碍学组. 中国成人失眠诊断与治疗指南(2017版)[J].中华神经科杂志, 2018, 51(5):324-335.
[8] 路桃影, 李艳, 夏萍,等. 匹兹堡睡眠质量指数的信度及效度分析[J].重庆医学, 2014,43(3):260-263.
[9] JIANG L, QING J G, JIN Z C, et al. Simultaneous liver, pancreas-duodenum and kidney transplantation in a patient with hepatitis B cirrhosis, uremia and insulin dependent diabetes mellitus[J].World J Gastroenterol,2017, 23(45):8104-8108.
[10] 刘莲, 张红霞, 崔书彦,等. 阿德福韦酯联合中药制剂治疗乙肝肝硬化疗效观察[J].现代中西医结合杂志, 2017, 26(21):2334-2336.
[11] 孟桂霞,王立蓉. 肝硬化患者失眠的因素及治疗预后探究[J].世界睡眠医学杂志, 2019,6(3):264-265.
[12] 陈宇杰, 石志敏, 李雪青. 乌梅丸联合驻车丸灌肠防治宫颈癌放疗所致急性放射性直肠炎的临床观察[J].中华中医药杂志, 2018,33(7):2975-2977.
[13] 王爱华, 李国焕. 乌梅丸治疗慢乙肝患者失眠经验总结[J].中国现代药物应用, 2017,11(6):178-180.
[14] 李晗, 严梅, 李炜弘,等. 严石林教授应用乌梅丸辨治肝阳虚的临床验案赏析[J].时珍国医国药, 2017,28(6):1467-1469.
[15] 张海华,丘丽华,汤琛,等.乌梅丸从肝治肺体会[J].山东中医杂志, 2018,37(6):524-525. |
|
|
|
2023, Vol. 40 
